$503.21
- Hardcover
488 pages
- Release Date
1 October 2027
Summary
Glycobiology provides a comprehensive overview of glycobiology, exploring the structure, function, and biology of carbohydrates and glycoconjugates in living organisms. Covering key topics such as glycan biosynthesis, glycoproteins, glycolipids, and the role of glycans in health and disease, the book serves as an essential resource for researchers, students, and professionals interested in the rapidly advancing field of glycobiology.
Book Details
| ISBN-13: | 9780443344114 |
|---|---|
| ISBN-10: | 0443344116 |
| Author: | Rossen Donev, Rolland Reinbold, Ileana Zucchi |
| Publisher: | Elsevier Science Publishing Co Inc |
| Imprint: | Academic Press Inc |
| Format: | Hardcover |
| Number of Pages: | 488 |
| Release Date: | 1 October 2027 |
| Dimensions: | 152mm x 229mm |
| Series: | Advances in Protein Chemistry and Structural Biology |
You Can Find This Book In
Rossen Donev
Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He completed postdoctoral training at the Imperial Cancer Research Fund (now Cancer Research UK) in London and at Cardiff University.
In 2007, he was awarded a New Investigator Grant from the Medical Research Council (UK) to establish his own independent research group. In 2010, Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016, he joined MicroPharm Ltd (UK) where he currently serves as Head of Research.
Dr. Donev has authored over 60 research publications, chaired scientific conferences, and delivered invited plenary talks. He has provided consultation on projects focused on developing treatments for neurodevelopmental disorders and cancer therapies. He is the Editor-in-Chief of “Advances in Protein Chemistry and Structural Biology” and serves on the editorial boards of several other scientific journals.
His research interests encompass signaling pathways involved in neuropsychiatric disorders and tumor immune evasion, as well as the development of therapeutic strategies for these conditions. More recently, his focus has shifted to the development of immunotherapeutics for non-systemic applications.
Returns
This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.